Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathieu Robain

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Therapie|March 14, 2018
Requests for post-registration studies (PRS), patients follow-up in actual practice: Changes in the role of databasesDriss Berdaï, Florence Thomas-Delecourt, Karine Szwarcensztein, et al.
F&S Science|May 13, 2022
Cyclic fertilin-derived peptide stimulates in vitro human embryo developmentAnne-Lyse Denizot, Audrey L'Hostis, Amira Sallem, et al.
Breast (Edinburgh, Scotland)|February 9, 2021
Outcome beyond third-line chemotherapy for metastatic triple-negative breast cancer in the French ESME programLuc Cabel, Matthieu Carton, Barbara Pistilli, et al.
BMC Medicine|March 7, 2023
Association between progression-free survival and overall survival in women receiving first-line treatment for metastatic breast cancer: evidence from the ESME real-world databaseCoralie Courtinard, Sophie Gourgou, William Jacot, et al.
International Journal of Cancer|May 16, 2019
Real-life activity of eribulin mesylate among metastatic breast cancer patients in the multicenter national observational ESME programWilliam Jacot, Pierre-Etienne Heudel, Julien Fraisse, et al.
Breast (Edinburgh, Scotland)|May 8, 2020
Impact of age at diagnosis of metastatic breast cancer on overall survival in the real-life ESME metastatic breast cancer cohortSophie Frank, Matthieu Carton, Coraline Dubot, et al.
European Journal of Cancer (Oxford, England : 1990)|July 23, 2019
Assessment of the efficacy of successive endocrine therapies in hormone receptor-positive and HER2-negative metastatic breast cancer: a real-life multicentre national studyOlivia Le Saux, Audrey Lardy-Cleaud, Sophie Frank, et al.
BMJ Open|February 24, 2019
The ongoing French metastatic breast cancer (MBC) cohort: the example-based methodology of the Epidemiological Strategy and Medical Economics (ESME)David Pérol, Mathieu Robain, Patrick Arveux, et al.
Breast (Edinburgh, Scotland)|December 11, 2020
Impact of body mass index on overall survival in patients with metastatic breast cancerKhalil Saleh, Matthieu Carton, Véronique Dieras, et al.
British Journal of Cancer|November 14, 2019
Impact of breast cancer molecular subtypes on the incidence, kinetics and prognosis of central nervous system metastases in a large multicentre real-life cohortAmélie Darlix, Guillaume Louvel, Julien Fraisse, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Therapie|March 14, 2018
Requests for post-registration studies (PRS), patients follow-up in actual practice: Changes in the role of databasesDriss Berdaï, Florence Thomas-Delecourt, Karine Szwarcensztein, et al.
F&S Science|May 13, 2022
Cyclic fertilin-derived peptide stimulates in vitro human embryo developmentAnne-Lyse Denizot, Audrey L'Hostis, Amira Sallem, et al.
Breast (Edinburgh, Scotland)|February 9, 2021
Outcome beyond third-line chemotherapy for metastatic triple-negative breast cancer in the French ESME programLuc Cabel, Matthieu Carton, Barbara Pistilli, et al.
BMC Medicine|March 7, 2023
Association between progression-free survival and overall survival in women receiving first-line treatment for metastatic breast cancer: evidence from the ESME real-world databaseCoralie Courtinard, Sophie Gourgou, William Jacot, et al.
International Journal of Cancer|May 16, 2019
Real-life activity of eribulin mesylate among metastatic breast cancer patients in the multicenter national observational ESME programWilliam Jacot, Pierre-Etienne Heudel, Julien Fraisse, et al.
Breast (Edinburgh, Scotland)|May 8, 2020
Impact of age at diagnosis of metastatic breast cancer on overall survival in the real-life ESME metastatic breast cancer cohortSophie Frank, Matthieu Carton, Coraline Dubot, et al.
European Journal of Cancer (Oxford, England : 1990)|July 23, 2019
Assessment of the efficacy of successive endocrine therapies in hormone receptor-positive and HER2-negative metastatic breast cancer: a real-life multicentre national studyOlivia Le Saux, Audrey Lardy-Cleaud, Sophie Frank, et al.
BMJ Open|February 24, 2019
The ongoing French metastatic breast cancer (MBC) cohort: the example-based methodology of the Epidemiological Strategy and Medical Economics (ESME)David Pérol, Mathieu Robain, Patrick Arveux, et al.
Breast (Edinburgh, Scotland)|December 11, 2020
Impact of body mass index on overall survival in patients with metastatic breast cancerKhalil Saleh, Matthieu Carton, Véronique Dieras, et al.
British Journal of Cancer|November 14, 2019
Impact of breast cancer molecular subtypes on the incidence, kinetics and prognosis of central nervous system metastases in a large multicentre real-life cohortAmélie Darlix, Guillaume Louvel, Julien Fraisse, et al.
Pageof 3